Linzagolix for treating moderate to severe symptoms of uterine fibroids: technology appraisal guidance

Woods, Lois, Kalita, Neelam, Hawa, Asyl, Scott, David Alexander and Frampton, Geoff (2024) Linzagolix for treating moderate to severe symptoms of uterine fibroids: technology appraisal guidance National Institute for Health and Care Excellence 156pp.

Record type: Monograph (Project Report)

Abstract

This report is a critique of the company’s submission (CS) to NICE from Theramex on the clinical effectiveness and cost effectiveness of linzagolix for treating moderate to severe symptoms of uterine fibroids. It identifies the strengths and weaknesses of the CS.

Text

Linzagolix EAG report - Version of Record

Available under License Other.

Download (3MB)

More information

Published date: 14 August 2024

Related URLs:

https://www.nice.org.uk/guidance/ta996

Identifiers

Local EPrints ID: 495567

URI: http://eprints.soton.ac.uk/id/eprint/495567

PURE UUID: 56b2c5b5-56ad-409e-a8f7-f650ed3132ef

ORCID for Lois Woods:

orcid.org/0000-0002-4587-9149

ORCID for Neelam Kalita:

orcid.org/0000-0002-0973-0160

ORCID for David Alexander Scott:

orcid.org/0000-0001-6475-8046

ORCID for Geoff Frampton:

orcid.org/0000-0003-2005-0497

Catalogue record

Date deposited: 18 Nov 2024 17:41

Last modified: 19 Nov 2024 02:58

Export record

Share this record

Share this on Facebook Share this on Twitter Share this on Weibo

Contributors

Author: Lois Woods

Author: Neelam Kalita

Author: Asyl Hawa

Author: David Alexander Scott

Author: Geoff Frampton

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Library staff additional information